Early or delayed parenteral nutrition for infants: what evidence is available?

Kwi Moon1,2,3, Shripada C Rao2,4

  • 1Pharmacy Department, Perth Children's Hospital, Nedlands.

Insights

Early parenteral nutrition benefits very premature infants, but high amino acid doses should be avoided. For older infants, delaying parenteral nutrition may be preferable to reduce infection risks, while monitoring key metabolic indicators is crucial.

Area of Science:

  • Neonatal nutrition
  • Pediatric intensive care
  • Clinical evidence synthesis

Background:

  • Parenteral nutrition (PN) is critical for infants unable to tolerate enteral feeding.
  • Optimal timing for initiating PN in different infant populations remains debated.
  • Evidence synthesis is needed to guide clinical practice regarding PN commencement.

Purpose of the Study:

  • To review current evidence on early versus delayed parenteral nutrition initiation in infants.
  • To evaluate the benefits and risks of early PN commencement across various infant age groups.
  • To provide evidence-based recommendations for PN timing in neonates and children.

Main Methods:

  • Systematic review of existing literature on parenteral nutrition timing.
  • Analysis of recent multicentre randomized controlled trials in premature infants and older children.
  • Evaluation of clinical outcomes including growth, metabolic complications, and infection rates.

Main Results:

  • Early PN commencement improves physical growth in very premature infants (<32 weeks gestation).
  • High early amino acid doses (>3.5 g/kg/day) may cause adverse metabolic effects.
  • Delayed PN (beyond 24 hours) in full-term infants/children may increase infection risk and ventilation duration, but very early initiation can risk hypoglycemia.

Conclusions:

  • Early PN is beneficial for very premature infants, with caution regarding high amino acid doses.
  • For moderate to late preterm infants, PN initiation after 72 hours of untolerated enteral feeds is reasonable.
  • Delayed PN (beyond 24 hours) is preferred for full-term and older infants, with careful monitoring of glucose and phosphate levels.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
482
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
478
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
779
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
137
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.2K